Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 01/28 01:45:00 am
60.27 EUR   -1.26%
01/25European ADRs Move Lower in Tuesday Trading
MT
01/25KIDNEYCARE : 365 CKD Program Earns NCQA Accreditation
PU
01/25FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan keeps a Sell rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fresenius Medical Care cuts jobs as Delta variant takes toll

11/02/2021 | 04:50am EST
FILE PHOTO: Rice Powell, CEO of Fresenius Medical Care, addresses the media during the company's annual news conference at their head quarters in Bad Homburg

(Reuters) - German dialysis specialist Fresenius Medical Care (FMC) plans to cut costs and up to 5,000 jobs globally - or about 4% of its workforce - as the Delta variant caused another spike in coronavirus-related patient deaths in the third quarter.

FMC had expected the death toll among dialysis patients, who are more susceptible to the virus, to normalise during the second half of the year, but said on Tuesday it now saw a decline in the mortality rate only in the fourth quarter.

"The existence of the Delta variant has caused excess mortality among our patients to rise again in the third quarter," Chief Executive Rice Powell said.

"This means that we must absorb a sizeably larger COVID-19 effect on our business than we projected at the beginning of the year."

The world's largest provider of dialysis treatments aims to reach annual cost cuts of 500 million euros ($580 million) by 2025, as it plans to replace its four regions and some global functions with two divisions: care enablement and care delivery.

Fresenius group, FMC's parent company, had previously announced plans to cut spending by 100 million euros a year in 2021-2025.

FMC maintained its forecast for net income to decline by a high-teens to mid-twenties percentage and sales growth in the low- to mid-single-digits, but warned the numbers would come in the lower end of the ranges.

Fresenius group firmed up its 2021 net income forecast after reporting quarterly results slightly above expectations.

JP Morgan analysts said Fresenius reported "a solid set of results" that should drive the shares today. "However, our concern on outer-year forecasts for FMC leaves us cautious on how much the shares can progress from here."

FMC's shares were up 2.5% at 0857 GMT, while Fresenius rose 4.3%.

($1 = 0.8619 euros)

(Reporting by Milla Nissi and Karol Badohal in Gdansk; Editing by Tomasz Janowski and Mark Potter)

By Milla Nissi


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA 2.31% 61.04 Delayed Quote.6.83%
FRESENIUS SE & CO. KGAA 1.45% 37.145 Delayed Quote.4.93%
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
01/25European ADRs Move Lower in Tuesday Trading
MT
01/25KIDNEYCARE : 365 CKD Program Earns NCQA Accreditation
PU
01/25FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan keeps a Sell rating
MD
01/25Fresenius Medical Care Reportedly in Talks to Buy Dmed Diyaliz
CI
01/19European ADRs Move Higher in Wednesday Trading
MT
01/18European ADRs Move Lower in Tuesday Trading
MT
01/17FMC FRESENIUS MEDICAL CARE AG & CO K : Sell rating from JP Morgan
MD
01/14European ADRs Move Higher in Friday Trading
MT
01/13FRESENIUS MEDICAL CARE : FKC Partners with Biim Ultrasound AS
PU
01/13Thyssenkrupp's hydrogen business gets KGaA structure
RE
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Financials (USD)
Sales 2021 20 119 M - -
Net income 2021 1 200 M - -
Net Debt 2021 12 831 M - -
P/E ratio 2021 16,7x
Yield 2021 1,98%
Capitalization 19 929 M 19 945 M -
EV / Sales 2021 1,63x
EV / Sales 2022 1,51x
Nbr of Employees 123 528
Free-Float 67,8%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 68,02 $
Average target price 75,79 $
Spread / Average Target 11,4%
EPS Revisions
Managers and Directors
Rice Powell Chief Executive Officer
Helen Giza Chief Financial & Transformation Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Executive VP-Clinical & Scientific Affairs
Sector and Competitors